Shares of drug maker Alkem Laboratories made a dream debut at the bourses today, surging over 31 per cent over the issue price of Rs 1,050.
The stock listed at Rs 1,380, a sharp gain of 31.42 per cent over the issue price, on the BSE. It touched a high of Rs 1,401.40 and a low of Rs 1,355.40 in early trade.
On NSE, the stock debuted at Rs 1,380, surging 31.42 per cent compared with the issue price.
The company commands a market valuation of Rs 16,486.22 crore.
Alkem has raised about Rs 1,350 crore at an issue price of Rs 1,050 per share from its recently-concluded IPO, which had got robust investor response with over-subscription of 44.29 times.
Qualified institutional buyers (QIBs) category was subscribed 57.19 times and retail investors bid 3.17 times. Non-institutional investors portion was subscribed 129.96 times.
Price band for the company’s IPO was fixed at Rs 1,020-1,050.
Prior to Alkem’s IPO, Dr Lal PathLabs, S H Kelkar, VRL Logistics, Power Mech Projects and Syngene International received strong response in terms of subscription so far this year.
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.